Profound knowledge of VEGF could allow therapeutic use of VEGF for a variety of human diseases that affect the neuronal dendrites such as Down syndrome, Rett syndrome and fragile X syndrome (Kaufmann and Moser, 2000). The gene discussed is VEGFA; the disease is Down syndrome.